Genetics of scleroderma: Update on single nucleotide polymorphism analysis and microarrays

Current Opinion in Rheumatology

Volumn 17, Issue 6, 2005, Pages 761-767

  Assassi, Shervin ^a   Tan, Filemon K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Genetic; Microarrays; Scleroderma; Systemic sclerosis

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE N ACETYLTRANSFERASE 2; BIOLOGICAL MARKER; CD19 ANTIGEN; CD19 ANTIGEN RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OSTEONECTIN; RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

DISEASE MARKER; DNA MICROARRAY; ENDOTHELIUM LESION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; IMMUNITY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCIBILITY; REVIEW; SAMPLE SIZE; SCLERODERMA; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA; HUMANS; MICROARRAY ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC;

EID: 27544506082     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000179943.27777.b1     Document Type: Review

References (47)

1. Arnett FC, Cho M, Chatterjee S, et al. Familial occurrence frequencies and relative risk for systemic sclerosis (scleroderma) in three United States cohort. Arthritis Rheum 2001; 44:1359-1362.
2. Feghali-Bostwick C, Medsger TAJ, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003; 48:1956-1963.
3. Yamane K, Ihn H, Asano Y, et al. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. J Immunol 2003; 171:3855-3862.
4. Sato H, Lagan A, Alexopoulou C, et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis Rheum 2004; 50:558-564. This study demonstrates the strong association of TNF promoter-1031 C allele with anti-centromere antibodies in a United Kingdom Caucasian population. This association might be able to explain the previously reported links between anticentromere antibody production and class II MHC alleles.
5. Morel PA, Chang HJ, Wilson JW, et al. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol 1995; 42:35-42.
6. Fanning GC, Welsh KI, Bunn C, et al. HLA associations in three mutually exclusive autantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 1998; 37:201-207.
7. Tolusso B, Fabris M, Caporali R, et al. -238 and +489 TNFα along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett 2005; 96:103-108.
8. Gharaee-Kermani M, Denholm EM, Phan SH, et al. Costimulation of fibroblast collagen and transforming growth factor beta 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996; 271:1779-1784.
9. Yamamoto T, Eckes B, Krieg T, et al. High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts. Eur J Immunol 2001; 31:2936-2941.
10. Galindo M, Santiago B, Rivero M, et al. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum 2001; 44:1382-1386.
11. Karrer S, Bosserhoff AK, Weiderer P, et al. The -2518 promoter polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 2005; 124:92-98. This study demonstrates the possible biological relevance of MCP-1 in systemic sclerosis.
12. Kawaguchi Y, Tochimoto A, Ichikawa N, et al. Association of IL1A gene polymorphism with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum 2003; 48:186-192.
13. Hutyrova B, Lukac J, Bosak V, et al. Interleukin 1 alpha single-nucleotide polymorphism associated with systemic sclerosis. J Rheumatol 2004; 31:81-84.
14. Takeuchi F, Kawasugi K, Nabeta H, et al. Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol 2002; 20:823-828.
15. Hudson LL, Silver RM, Pandey JP. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J Rheumatol 2004; 31:85-87.
16. Momot T, Koch S, Hunzelmann N, et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004; 50:1561-1565.
17. Tedder TF, Inoaki M, Sato S. The CD 19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 1997; 6:107-118.
18. Tsuchiya N, Kuroki K, Fujimoto M, et al. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum 2004; 50:4002-4007. This study shows an association of CD19-449T allele with systemic sclerosis in a Japanese population and correlates it with functional data.
19. Cotton SA, Herrick AL, Jayson MI, et al. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 1999; 189:273-278.
20. Fatini C, Gensini F, Sticchi E, et al. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 2002; 112:540-544.
21. Biondi ML, Marasini B, Leviti S, et al. Genotyping method for point mutation detection in the endothelial nitric oxide exon 7 using fluorescent probes. Clin Chem Lab Med 2001; 39:281-282.
22. phox NADPH oxidase subunit (C242T) polymorphism with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta 2004; 350:51-55.
23. Assassi S, Mayes MD, McNearney T, et al. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am J Med 2005; 118:907-911.
24. phox is a critical component of the superoxide generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271:23317-23321.
25. Tew MB, Reveille JD, Arnett F, et al. Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun 2001; 2:236-238.
26. Tikly M, Marshall S, Haldar N, et al. Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis. Rad Biol Med 2004; 36:1403-1407.
27. Skretkowicz K, Skretkowicz J, Gawronska-Szklarz B, et al. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis. Eur J Clin Pharmacol 2005; 60:773-778.
28. Unemori EN, Amento EP. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1991; 3:953-959.
29. Zhou X, Tan FK, Reveille JD, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002; 46:2990-2999.
30. Lagan AL, Pantelidis P, Renzoni EA, et al. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatol 2005; 44:197-201. A study of five novel SNPs in the SPARC gene. None of these polymorphisms or three previously reported ones are associated with systemic sclerosis in a United Kingdom white population.
31. Valk PJM, Verhaak RGW, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350:1617-1628.
32. Bullinger L, Doehner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350:1605-1616.
33. Simon RM, Dobbin K. Experimental design of DNA microarray experiments. Biotechniques 2003; 34:S16-S21.
34. Monks SA, Leonardson A, Zhu H, et al. Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 2004; 75:1094-1105.
35. Whitfield ML, Finlay DR, Murray JI, et al. Systemic and cell type-specific gene expression pattern in scleroderma skin. Proc Natl Acad Sci U S A 2003; 100:12319-12324.
36. Claman HN, Giomo RC, Seibold JR. Endothelial and fibroblastic activation in scleroderma: the myth of the 'uninvolved skin.' Arthritis Rheum 1991; 34:1495-1501.
37. Tan FK, Hildebrand BA, Lester MS, et al. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 2005; 52: 865-876. A large study of nonlesional dermal fibroblasts from patients with systemic sclerosis and controls. Only a small fraction of genes were found to be differentially expressed, but they affect a wide variety of biologic processes.
38. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theo Population Biol 2001; 60:155-166.
39. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55:997-1004.
40. Devlin B, Bacanu S, Roeder K. Genomic control to the extreme. Nat Genet 2004; 36:1129-1131.
41. Long AD, Langley CH. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res 1999; 9:720-731.
42. Van den Oord EJ, Sullivan PF. A framework for controlling false discovery rates and minimizing the amount of genotyping in the search for disease mutations. Hum Hered 2003; 56:188-199.
43. Risch N, Merikangas KR. The future of genetic studies of complex human diseases. Science 1996; 273:1516-1517.
44. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75:353-362.
45. Van den Oord EJ, Sullivan PF. False discoveries and models for gene discovery. Trends Genet 2003; 19:537-542.
46. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75:330-337.
47. Kyogoku C, Langefeld CD, Ortmann WA, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75:504-507.